New research highlights role of dietary antioxidants in reducing erectile dysfunction risk

Researchers assess the association between erectile dysfunction and the Compound Dietary Antioxidant Index.

Phathom wins label expansion on heartburn drug to include non-erosive patients

Phathom Pharmaceuticals is digesting news of an expanded label for its heartburn drug Voquezna. The FDA on Wednesday afternoon approved the drug for the relief

July 19, 2024

FDA grants second orphan drug designation to Priothera’s mocravimod – Pharmaceutical Technology

Share this article The drug is indicated to help improve the outcome of patients with haematologic malignancies following a haematopoietic stem cell transplantation. Image credit:

November 27, 2023

High-dose psilocybin shows promise for depression treatment

Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.